Ładuje się......
Cell death in response to antimetabolites directed at ribonucleotide reductase and thymidylate synthase
New agent development, mechanistic understanding, and combinatorial partnerships with known and novel modalities continue to be important in the study of pancreatic cancer and its improved treatment. In this study, known antimetabolite drugs such as gemcitabine (ribonucleotide reductase inhibitor) a...
Zapisane w:
| Wydane w: | Onco Targets Ther |
|---|---|
| Główni autorzy: | , , , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Dove Medical Press
2015
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4354452/ https://ncbi.nlm.nih.gov/pubmed/25767396 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S79647 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|